{"introduction": {"name": "Anti-arrhythmic Drugs"}, "classification": [{"part": [{"name": "Moderately decrease dv/dt of 0 phase", "part": [{"name": "Quinidine"}, {"name": "Procainamide"}, {"name": "Disopyramide"}]}, {"name": "Little decrease dv/dt of 0 phase", "part": [{"name": "Lidocaine"}, {"name": "Mexiletine"}, {"name": "Tocainide"}]}, {"name": "Marked decrease dv/dt of 0 phase", "part": [{"name": "Propafenone"}, {"name": "Encainide"}, {"name": "Flecainide"}]}], "class": "Class-I", "other_name": "Membrane stabilizing agents", "other_name_1": "Na+ channel blocker"}, {"part": [{"name": "Propranolol"}, {"name": "Esmolol"}, {"name": "Sotalol"}], "class": "Class-II", "other_name": "Î²-blocker"}, {"part": [{"name": "Amiodarone"}, {"name": "Bretylium"}, {"name": "Dofetilide"}, {"name": "Ibutilide"}], "class": "Class-III", "other_name": "Agent widening AP (prolong repolarization and ERP)"}, {"part": [{"name": "Verapamil"}, {"name": "Diltiazem"}], "class": "Class-IV", "other_name": "Calcium channel blockers"}]}